neither good nor bad.
relevant: Because the nephrology community and FDA will want to see how DXB200 performs when used in patients also taking sglt2 inhibitors such as forxiga, jardiance etc. we need to know how many in the phase 3 action trial are on sglt2 inhibitors.
- Forums
- ASX - By Stock
- DXB
- DXB Media thread.
DXB
dimerix limited
Add to My Watchlist
0.00%
!
51.5¢
DXB Media thread., page-857
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.